Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Aichi, Japan

Aichi, Japan

Aichi, Japan

Aichi, Japan

Akita, Japan

Akita, Japan

Aomori, Japan

Aomori, Japan

Aomori, Japan

Chiba, Japan

Chiba, Japan

Ehime, Japan

Fukuoka, Japan

Fukuoka, Japan

Fukuoka, Japan

Fukuoka, Japan

Fukuoka, Japan

Fukuoka, Japan

Fukuoka, Japan

Fukushima, Japan

Fukushima, Japan

Gifu, Japan

Gunma, Japan

Hiroshima, Japan

Hiroshima, Japan

Hiroshima, Japan

Hiroshima, Japan

Hokkaido, Japan

Hokkaido, Japan

Hokkaido, Japan

Hokkaido, Japan

Hokkaido, Japan

Hokkaido, Japan

Hyōgo, Japan

Hyōgo, Japan

Hyōgo, Japan

Ishikawa, Japan

Kagoshima, Japan

Kagoshima, Japan

Kagoshima, Japan

Kanagawa, Japan

Kanagawa, Japan

Kanagawa, Japan

Kanagawa, Japan

Kanagawa, Japan

Kanagawa, Japan

Kanagawa, Japan

Kumamoto, Japan

Kumamoto, Japan

Kyoto, Japan

Miyagi, Japan

Miyagi, Japan

Nagano, Japan

Nagano, Japan

Nagano, Japan

Nagasaki, Japan

Nara, Japan

Okinawa, Japan

Okinawa, Japan

Okinawa, Japan

Osaka, Japan

Osaka, Japan

Ōita, Japan

Saga, Japan

Saga, Japan

Saitama, Japan

Shiga, Japan

Shimane, Japan

Shizuoka, Japan

Tokyo, Japan

Tokyo, Japan

Tokyo, Japan

Tokyo, Japan

Tokyo, Japan

Tokyo, Japan

Tokyo, Japan

Tokyo, Japan

Tokyo, Japan

Toyama, Japan

Toyama, Japan

Yamagata, Japan

Yamaguchi, Japan